Autonomic Test by EZSCAN in the Screening for Prediabetes and Diabetes

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Yang, Zhi ^a   Xu, Baihui ^a   Lu, Jieli ^a   Tian, Xiaoguang ^a   Li, Mian ^a   Sun, Kan ^a   Huang, Fei ^a   Liu, Yu ^a   Xu, Min ^a   Bi, Yufang ^a   Wang, Weiqing ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; AUTOANALYSIS; AUTONOMIC DYSFUNCTION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DYSGLYCEMIA; EZSCAN TEST; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SENSITIVITY ANALYSIS; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE; RISK FACTORS;

EID: 84873730500     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056480     Document Type: Article

References (29)

1. Whiting DR, Guariguata L, Weil C, Shaw J, (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94: 311-321.
2. Yang W, Lu J, Weng J, Jia W, Ji L, et al. (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362: 1090-1101.
3. Isak B, Oflazoglu B, Tanridag T, Yitmen I, Us O, (2008) Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance. Diabetes Metab Res Rev 24: 563-569.
4. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, et al. (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33: 2285-2293.
5. England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, et al. (2009) Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (anevidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 72: 177-184.
6. Illigens BM, Gibbons CH, (2009) Sweat testing to evaluate autonomic function. Clin Auton Res 19: 79-87.
7. Mayaudon H, Miloche PO, Bauduceau B, (2010) A new simple method for assessing sudomotor function: relevance in type 2 diabetes. Diabetes Metab 36: 450-454.
8. Ramachandran A, Moses A, Shetty S, Thirupurasundari CJ, Seeli AC, et al. (2010) A new non-invasive technology to screen for dysglycaemia including diabetes. Diabetes Res Clin Pract 88: 302-306.
9. Sheng CS, Zeng WF, Huang QF, Deslypere JP, Li Y, et al. (2011) Accuracy of a Novel Non-Invasive technology based EZSCAN system for the diagnosis of diabetes mellitus in Chinese. Diabetol Metab Syndr 3: 36.
10. Vinik AI, Maser RE, Mitchell BD, Freeman R, (2003) Diabetic autonomic neuropathy. Diabetes Care 26: 1553-1579.
11. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. (2003) The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Croat Med J 44: 639-50.
12. Sun K, Liu Y, Dai M, Li M, Yang Z, et al. (2012) Accessing autonomic function can early screen metabolic syndrome. PLoS One 7: e43449.
13. Chizmadzhev YA, Indenbom AV, Kuzmin PI, Galichenko SV, Weaver JC, et al. (1998) Electrical properties of skin at moderate voltages: contribution of appendageal macropores. Biophys J 74: 843-856.
14. Brunswick P, Mayaudon H, Albin V, Lair V, Ringuede A, et al. (2007) Use of Ni electrodes chronoamperometry for improved diagnostics of diabetes and cardiac diseases. Conf Proc IEEE Eng Med Biol Soc 2007: 4544-4547.
15. Schwarz P, Brunswick P, Calvet JH, (2011) EZSCAN™ a new technology to detect diabetes risk. British Journal of Diabetes and Vascular Disease 11: 204-209.
16. Pencina MJ, D'Agostino RB, (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 23: 2109-2123.
17. American Diabetes Association (2012) Standards of Medical Care inDiabete-2012. Diabetes Care 35 Suppl 1: S11-63.
18. Gallop RJ, Crits-Christoph P, Muenz LR, Tu XM, (2003) Determination and interpretation of the optimal operating point for ROC curves derived through generalized linear models. Understanding Statistics 2: 219-242.
19. Zhou BF, (2002) Cooperative Meta-Analysis Group of the Working Group on Obesity in China (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15: 83-96.
20. Licht CM, Vreeburg SA, van Reedt Dortland AK, Giltay EJ, Hoogendijk WJ, et al. (2010) Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab 95: 2458-2466.
21. Watkins LL, Surwit RS, Grossman P, Sherwood A, (2000) Is there a glycemic threshold for impaired autonomic control? Diabetes Care 23: 826-830.
22. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M, (2003) The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60: 108-111.
23. Rajabally YA, (2011) Neuropathy and impaired glucose tolerance: an updated review of the evidence. Acta Neurol Scand 124: 1-8.
24. Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabó E, et al. (2002) The role of poly-(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51: 514-521.
25. Edwards JL, Vincent AM, Cheng HT, Feldman EL, (2008) Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120: 1-34.
26. Pop-Busui R, (2010) Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care 33: 434-441.
27. Vinik AI, Maser RE, Ziegler D, (2011) Autonomic imbalance: prophet of doom or hope? Diabet Med 28: 643-651.
28. Dyck PJ, Davies JL, Clark VM, Litchy WJ, Dyck PJ, et al. (2006) Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care 29: 2282-2288.
29. Ozaki R, Cheung KK, Wu E, Kong A, Yang X, et al. (2011) A New Tool to Detect Kidney Disease in Chinese Type 2 Diabetes Patients: Comparison of EZSCAN with Standard Screening Methods. Diabetes Technol Ther 13: 937-943.